Patents Assigned to AMPAC Fine Chemicals LLC
  • Patent number: 10851063
    Abstract: A method for producing substantially pure levorphanol and related compounds, when compared to the conventional process, is provided. In particular, a method for producing substantially pure levorphanol tartrate dihydrate is described. Also described are compositions comprising levorphanol and related compounds, particularly compositions comprising levorphanol tartrate dihydrate, levomethorphan, and norlevorphanol in which the levomethorphan and norlevorphanol are present in the composition in reduced levels.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: December 1, 2020
    Assignee: AMPAC FINE CHEMICALS LLC
    Inventors: William Dubay, Alex Nichols, Wei Chen, Alec Brozell, Ajay Ryerson
  • Patent number: 10307431
    Abstract: An improved lyophilized cyclophosphamide solid composition is described. The lyophilized cyclophosphamide solid composition is thermally stable, contains anhydrous cyclophosphamide and mannitol, and is substantially free of cyclophosphamide monohydrate. A method for preparing the lyophilized cyclophosphamide solid composition is also provided.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: June 4, 2019
    Assignee: AMPAC Fine Chemicals LLC
    Inventors: Andrew M. Smith, Timothy S. Dutill, Edward H. Trappler
  • Patent number: 10149857
    Abstract: An improved lyophilized cyclophosphamide solid composition is described. The lyophilized cyclophosphamide solid composition is thermally stable, contains anhydrous cyclophosphamide and mannitol, and is substantially free of cyclophosphamide monohydrate. A method for preparing the lyophilized cyclophosphamide solid composition is also provided.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: December 11, 2018
    Assignee: AMPAC Fine Chemicals LLC
    Inventors: Andrew M. Smith, Timothy S. Dutill, Edward H. Trappler
  • Patent number: 9573896
    Abstract: Novel methods and systems for producing a substantially pure d-threo stereoisomer of methylphenidate or a salt thereof are provided. In particular, methods and systems for producing d-threo-methylphenidate hydrochloride in pure stereoisomeric form from d-threo-ritalinic acid hydrochloride using diazomethane are described. The described methods can be performed on a large scale, and thus provide d-threo methylphenidate or a salt thereof, and particularly the hydrochloride salt of d-threo-methylphenidate, in stereoisomerically pure form and in large quantities from a single batch reaction. Also described are novel compositions of d-threo methylphenidate hydrochloride.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: February 21, 2017
    Assignee: AMPAC Fine Chemicals LLC
    Inventors: Aslam Malik, Francis Hempenstall, Nicholas Duda, Ali Suleman
  • Patent number: 9233924
    Abstract: Novel methods and systems for producing a substantially pure d-threo stereoisomer of methylphenidate or a salt thereof are provided. In particular, methods and systems for producing d-threo-methylphenidate hydrochloride in pure stereoisomeric form from d-threo-ritalinic acid hydrochloride using diazomethane are described. The described methods can be performed on a large scale, and thus provide d-threo methylphenidate or a salt thereof, and particularly the hydrochloride salt of d-threo-methylphenidate, in stereoisomerically pure form and in large quantities from a single batch reaction. Also described are novel compositions of d-threo methylphenidate hydrochloride.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: January 12, 2016
    Assignee: AMPAC Fine Chemicals LLC
    Inventors: Aslam Malik, Francis Hempenstall, Nicholas Duda, Ali Suleman
  • Publication number: 20150259289
    Abstract: Novel methods and systems for producing a substantially pure d-threo stereoisomer of methylphenidate or a salt thereof are provided. In particular, methods and systems for producing d-threo-methylphenidate hydrochloride in pure stereoisomeric form from d-threo-ritalinic acid hydrochloride using diazomethane are described. The described methods can be performed on a large scale, and thus provide d-threo methylphenidate or a salt thereof, and particularly the hydrochloride salt of d-threo-methylphenidate, in stereoisomerically pure form and in large quantities from a single batch reaction. Also described are novel compositions of d-threo methylphenidate hydrochloride.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 17, 2015
    Applicant: AMPAC FINE CHEMICALS LLC
    Inventors: Aslam MALIK, Francis HEMPENSTALL, Nicholas DUDA, Ali SULEMAN
  • Patent number: 9090539
    Abstract: Compounds and methods for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds from an isomerically pure starting material are described. In particular, methods of preparing a 3-(1-(dimethylamino)-2-methylpentane-3-yl)phenol as a substantially optically pure (R,R) stereoisomer are described. Using a method of the present invention, only the (R,R) and (S,S) stereoisomers of the target compound are produced, increasing the yield and stereoselectivity of the desired (R,R) stereoisomer.
    Type: Grant
    Filed: May 24, 2013
    Date of Patent: July 28, 2015
    Assignee: AMPAC Fine Chemicals LLC
    Inventors: Brian Morgan, Olivier Dapremont, Patrick Berget, Ali Suleman, William Dubay, Jeffrey D. Butler
  • Publication number: 20150114315
    Abstract: A method for releasing an anhydrous gas in a gas phase at a target rate includes the step of obtaining a vessel at least partially filled with the anhydrous gas. The anhydrous gas is at least partially in a liquid phase and the vessel has an outlet for releasing the anhydrous gas in the gas phase. The method further includes releasing at least a portion of the anhydrous gas from the vessel through the outlet in the gas phase; applying a heat transfer fluid having a temperature of 32° F. to 150° F. to an exterior surface of the vessel during the releasing step, such that the anhydrous gas in the liquid phase is evaporated and the anhydrous gas in the gas phase is released at the target rate; and measuring starting and end weights of the vessel to monitor the releasing of the anhydrous gas in the gas phase.
    Type: Application
    Filed: October 31, 2013
    Publication date: April 30, 2015
    Applicant: AMPAC FINE CHEMICALS LLC
    Inventors: Brian C. LIPPSMEYER, Grant M. GONTARSKI, Ryan P. THIBAULT, Ben L. BENNING
  • Patent number: 8835684
    Abstract: The present invention provides a new process for the preparation of 2R,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride, wherein this compound is prepared directly from the chloromethylalcohol. Importantly, the process of the present invention results in higher yields of 2R,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride without sacrificing its purity. The processes of the present invention can be used to prepare not only the 2R,3S-derivative, but also the 2S,3S-, 2S,2R- and the 2R,3R-derivatives.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: September 16, 2014
    Assignee: Ampac Fine Chemicals LLC
    Inventors: Aslam A. Malik, Hasan Palandoken, Joy A. Stringer, Roland P. Carlson, John Leach, Thomas G. Archibald, Robert G. Miotke
  • Publication number: 20140051888
    Abstract: A novel stereochemical mixture of 1,6-diaryl-2,5-diaminohexanes, such as a mixture of stereoisomers of 1,6-diphenylhexane-2,5-diamine, is described. Also described are methods of preparing stereochemically pure 1,6-diaryl-2,5-diaminohexanes, and particularly stereochemically pure 1,6-diphenyl-2,5-diaminohexane. Also described is the use of both the mixture of stereoisomers and the individual stereoisomers.
    Type: Application
    Filed: July 31, 2013
    Publication date: February 20, 2014
    Applicant: AMPAC FINE CHEMICALS LLC
    Inventors: William DUBAY, Jeffrey D. BUTLER, Charles L. LIOTTA
  • Patent number: 8357302
    Abstract: Product yields in chemical reactions that produce a solid product from a liquid reaction mixture are improved by chromatographically separating certain key impurities from the product mixture prior to crystallization, or from the filtrate after crystallization in which case further product is crystallized from the filtrate. The removal of key impurities either before the first crystallization or between the first and second crystallizations facilitates the crystallization of product to produce a higher yield of product.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: January 22, 2013
    Assignee: Ampac Fine Chemicals LLC
    Inventors: Olivier Dapremont, Aslam Malik
  • Patent number: 8198461
    Abstract: The present invention provides compounds and methods that can be used to convert 1,2,4-triazole-3-carboxamides to the corresponding 3-cyano-1,2,4-triazoles reliably in one step, with high yields and without the need for elaborate purification.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: June 12, 2012
    Assignee: AMPAC Fine Chemicals LLC.
    Inventors: Der-Shing Huang, Benjamin Mendoza, Aslam A. Malik
  • Patent number: 8163933
    Abstract: The present invention provides compounds and methods that can be used to convert the intermediate halomethyl ketones (HMKs), e.g., chloromethyl ketones, to the corresponding S,S- and R,S-diastereomers. More particularly, the present invention provides: (1) reduction methods; (2) inversion methods; and (3) methods involving the epoxidation of alkenes. Using the various methods of the present invention, the R,S-epoxide and the intermediary compounds can be prepared reliably, in high yields and in high purity.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: April 24, 2012
    Assignee: Ampac Fine Chemicals LLC
    Inventors: Aslam A. Malik, Todd E. Clement, Hasan Palandoken, James Robinson, III, Joy A. Stringer
  • Publication number: 20120024785
    Abstract: Product yields in chemical reactions that produce a solid product from a liquid reaction mixture are improved by chromatographically separating certain key impurities from the product mixture prior to crystallization, or from the filtrate after crystallization in which case further product is crystallized from the filtrate. The removal of key impurities either before the first crystallization or between the first and second crystallizations facilitates the crystallization of product to produce a higher yield of product.
    Type: Application
    Filed: July 26, 2011
    Publication date: February 2, 2012
    Applicant: Ampac Fine Chemicals LLC, a California Limited Liability Company
    Inventors: Olivier Dapremont, Aslam Malik
  • Patent number: 8080674
    Abstract: R-?-Lipoic acid and its homologs are converted to their magnesium salts in the presence of a reduced form of the acid, dihydro-(+)-lipoic acid in the case of R-?-lipoic acid itself. The reduced form serves as a polymerization inhibitor, resulting in a Mg di-R-?-lipoate product of higher purity. The reduced acid retained in the product tends to convert to the starting acid, thereby avoiding the inclusion of an extraneous polymerization inhibitor in the product.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: December 20, 2011
    Assignee: Ampac Fine Chemicals LLC.
    Inventor: Fang-Ting Chiu
  • Patent number: 8076511
    Abstract: High yields and purity are obtained in the purification of enantiomers of chiral carboxylic acids by preparative-scale chromatography by including a tertiary alcohol in the mobile phase in conjunction with an acidic modifier and a hydrophobic solvent. The tertiary alcohol is superior to other, more commonly used alcohols by reducing the extent of esterification of the enantiomer that otherwise lowers the yield and the purity.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: December 13, 2011
    Assignee: Ampac Fine Chemicals LLC.
    Inventors: Der-Shing Huang, Olivier Dapremont, Patrick Berget, Xa Her, Darin Sanchez
  • Publication number: 20100317873
    Abstract: R-?-Lipoic acid and its homologs are converted to their magnesium salts in the presence of a reduced form of the acid, dihydro-(+)-lipoic acid in the case of R-?-lipoic acid itself. The reduced form serves as a polymerization inhibitor, resulting in a Mg di-R-?-lipoate product of higher purity. The reduced acid retained in the product tends to convert to the starting acid, thereby avoiding the inclusion of an extraneous polymerization inhibitor in the product.
    Type: Application
    Filed: June 12, 2009
    Publication date: December 16, 2010
    Applicant: Ampac Fine Chemicals LLC, a California Limited Liability Company
    Inventor: Fang-Ting Chiu
  • Publication number: 20100286444
    Abstract: The present invention provides a new process for the preparation of 2R,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride, wherein this compound is prepared directly from the chloromethylalcohol. Importantly, the process of the present invention results in higher yields of 2R,35-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride without sacrificing its purity. The processes of the present invention can be used to prepare not only the 2R,3S-derivative, but also the 2S,3S-, 2S,2R- and the 2R,3R-derivatives.
    Type: Application
    Filed: July 21, 2010
    Publication date: November 11, 2010
    Applicant: Ampac Fine Chemicals LLC
    Inventors: Aslam A. Malik, Hasan Palandoken, Joy A. Stringer, Roland P. Carlson, John Leach, Thomas G. Archibald, Robert G. Miotke
  • Patent number: 7807850
    Abstract: The present invention provides a new process for the preparation of 2R,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbuty1)-p-nitrobenzenesulfonylamide hydrochloride, wherein this compound is prepared directly from the chloromethylalcohol. Importantly, the process of the present invention results in higher yields of 2R,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride without sacrificing its purity. The processes of the present invention can be used to prepare not only the 2R,3S-derivative, but also the 2S,3S-, 2S,2R- and the 2R,3R-derivatives.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: October 5, 2010
    Assignee: Ampac Fine Chemicals LLC
    Inventors: Aslam A. Malik, Hasan Palandoken, Joy A. Stringer, Roland P. Carlson, John Leach, Thomas G. Archibald, Robert G. Miotke
  • Publication number: 20090292122
    Abstract: The present invention provides compounds and methods that can be used to convert nitrogen-containing-heteroaryl carboxamides to the corresponding nitrogen-containing-heteroaryl nitriles reliably in one step, with high yields and without the need for elaborate purification.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 26, 2009
    Applicant: Ampac Fine Chemicals LLC
    Inventors: Der-Shing Huang, Benjamin Mendoza, Aslam A. Malik